Correspondently, NLRP3 gene knockout restored the ZO-1/2 impairment and microvascular hyperpermeability induced by circulating NAFLD hepatic sEVs (Fig. 3G–J). This evidence concerns the gene NLRP3 and metabolic dysfunction-associated steatotic liver disease.